Author:
Khairnar Pooja Sanjay,Singh Ajit,Shukla Rahul
Reference111 articles.
1. Aboutaleb E, Noori M, Gandomi N, Atyabi F, Fazeli MR, Jamalifar H et al (2012) Improved antimycobacterial activity of rifampin using solid lipid nanoparticles. Int Nano Lett 2(1):33
2. Agatonovic-Kustrin S, Glass BD, Wisch MH, Alany RG (2003) Prediction of a stable microemulsion formulation for the oral delivery of a combination of antitubercular drugs using ANN methodology. Pharm Res 20(11):1760–1765
3. Ahmad Z, Sharma S, Khuller GK (2005) Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int J Antimicrob Agents 26(4):298–303
4. Ahmad Z, Pandey R, Sharma S, Khuller GK (2006) Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential. Indian J Chest Dis Allied Sci 48(3):171–176
5. Ahmed M, Ramadan W, Rambhu D, Shakeel F (2008) Potential of nanoemulsions for intravenous delivery of rifampicin. Pharmazie 63(11):806–811